Toshali Pandey, Sajjad Akbar Bhatti. "Survival and safety of two year-fixed duration vs continuous immune checkpoint inhibitor therapy in advanced or metastatic NSCLC: A systematic review.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.8584